Literature DB >> 6265427

Comparative in-vitro activity of moxalactam and cefotaxime against isolates from blood culture.

C H Ramirez-Ronda, M Nevarez, S Saavedra, R H Bermudez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6265427     DOI： 10.1093/jac/7.6.629

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms.

Authors:  C J Schleupner
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Comparative activities of 13 beta-lactam antibiotics.

Authors:  H L Muytjens; J van der Ros-van de Repe
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

3.  False-susceptible results from the MS-2 system used for testing resistant Pseudomonas aeruginosa against two third-generation cephalosporins, moxalactam and cefotaxime.

Authors:  L L Stone; D L Jungkind
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

Review 4.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.